OFIX · Orthofix Medical Inc.
$10.34
+0.16 (+1.57%)
At close · Aug 14
Market Cap
$421.18M
Shares
40.73M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Vickie Capps | director | Appointed | 2025-03-12 |
| John B. Henneman, III | Chair of the Nominating, Governance and Sustainability Committee of the Board | Appointed | 2024-06-20 |
| Jason M. Hannon | Chair of the Compliance and Ethics Committee of the Board | Appointed | 2024-06-20 |
| Wayne Burris | Chair of the Audit and Finance Committee of the Board | Appointed | 2024-06-20 |
| Charles R. Kummeth | Chair of the Compensation and Talent Development Committee of the Board | Appointed | 2024-06-20 |
| Michael M. Finegan | Chair of the Board | Appointed | 2024-06-20 |
| Julie Andrews | Chief Financial Officer | Appointed | 2024-01-17 |
| Massimo Calafiore | Director | Appointed | 2024-01-09 |
| Julie Andrews | Chief Financial Officer | Appointed | 2024-01-09 |
| Massimo Calafiore | President and Chief Executive Officer | Appointed | 2024-01-09 |
| Michael M. Finegan | director | Appointed | 2023-12-15 |
| Charles R. Kummeth | director | Appointed | 2023-12-15 |
| Alan L. Bazaar | director | Appointed | 2023-12-15 |
| Massimo Calafiore | President and Chief Executive Officer | Appointed | 2023-12-01 |
| Keith C. Valentine | member of the Board of Directors | Resigned | 2023-10-05 |
| Puja Leekha | Interim Chief Legal Officer | Appointed | 2023-09-14 |
| Geoffrey C. Gillespie | Interim Chief Financial Officer | Appointed | 2023-09-14 |
| Patrick Keran | Chief Legal Officer | Terminated | 2023-09-14 |
| Catherine M. Burzik | Interim Chief Executive Officer | Appointed | 2023-09-14 |
| John Bostjancic | Chief Financial Officer | Terminated | 2023-09-14 |
| Keith Valentine | Chief Executive Officer | Terminated | 2023-09-14 |
| Catherine Burzik | Chair of the Company's Board of Directors | Appointed | 2023-06-20 |
| Wayne Burris | Audit and Finance and Compliance and Ethics Committees of the Company's Board of Directors | Appointed | 2023-06-20 |
| Catherine M. Burzik | Chair of the Company's Board of Directors | Appointed | 2023-06-20 |
| Michael Paolucci | Independent Director | Appointed | 2023-01-05 |
Key facts
CIK
884624
CUSIP
68752M108
13F (30d)
131 filings
129 filers
Visit website
Investor relations